Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Olivier Peters

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nephrologie & Therapeutique|July 15, 2010
[Workload during hemodialysis sessions]Nicolas Olivier Peters, Joëlle Cridlig, Carole Loos-Ayav, et al.
Nephrologie & Therapeutique|December 4, 2015
[T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data]Alexandre Martin, Nathalie Thilly, Carole Ayav, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nephrologie & Therapeutique|July 15, 2010
[Workload during hemodialysis sessions]Nicolas Olivier Peters, Joëlle Cridlig, Carole Loos-Ayav, et al.
Nephrologie & Therapeutique|December 4, 2015
[T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data]Alexandre Martin, Nathalie Thilly, Carole Ayav, et al.
Pageof 1